123 related articles for article (PubMed ID: 32419549)
1. Autograft cellular composition and outcome in NHL patients: results of the prospective multicenter GOA study.
Turunen A; Valtola J; Partanen A; Ropponen A; Kuittinen O; Kuitunen H; Vasala K; Ågren L; Penttilä K; Keskinen L; Savolainen ER; Pyörälä M; Kuittinen T; Selander T; Mäntymaa P; Pelkonen J; Jantunen E; Varmavuo V
Leuk Lymphoma; 2020 Sep; 61(9):2082-2092. PubMed ID: 32419549
[TBL] [Abstract][Full Text] [Related]
2. Autograft cellular composition and outcome in myeloma patients: Results of the prospective multicenter GOA study.
Turunen A; Silvennoinen R; Partanen A; Valtola J; Siitonen T; Putkonen M; Sankelo M; Pyörälä M; Kuittinen T; Penttilä K; Sikiö A; Savolainen ER; Mäntymaa P; Pelkonen J; Varmavuo V; Jantunen E
Transfusion; 2021 Jun; 61(6):1830-1844. PubMed ID: 33955591
[TBL] [Abstract][Full Text] [Related]
3. Mobilization characteristics, blood graft composition, and outcome in diffuse large B-cell lymphoma after autologous stem cell transplantation: Results from the prospective multicenter GOA study.
Partanen A; Turunen A; Valtola J; Pyörälä M; Vasala K; Kuittinen O; Kuitunen H; Penttilä K; Keskinen L; Kuittinen T; Mäntymaa P; Pelkonen J; Varmavuo V; Jantunen E
Transfusion; 2021 Feb; 61(2):516-525. PubMed ID: 33245582
[TBL] [Abstract][Full Text] [Related]
4. CD34+ cell mobilization, blood graft composition, and posttransplant recovery in myeloma patients compared to non-Hodgkin's lymphoma patients: results of the prospective multicenter GOA study.
Turunen A; Partanen A; Valtola J; Ropponen A; Siitonen T; Kuittinen O; Kuitunen H; Putkonen M; Sankelo M; Keskinen L; Savolainen ER; Pyörälä M; Kuittinen T; Silvennoinen R; Penttilä K; Sikiö A; Vasala K; Mäntymaa P; Pelkonen J; Varmavuo V; Jantunen E
Transfusion; 2020 Jul; 60(7):1519-1528. PubMed ID: 32333404
[TBL] [Abstract][Full Text] [Related]
5. Loss of CD34
Partanen A; Turunen A; Valtola J; Pyörälä M; Kuittinen O; Kuitunen H; Vasala K; Penttilä K; Kuittinen T; Mäntymaa P; Pelkonen J; Jantunen E; Varmavuo V
Clin Lymphoma Myeloma Leuk; 2023 Nov; 23(11):e428-e435. PubMed ID: 37684185
[TBL] [Abstract][Full Text] [Related]
6. Autograft immune content and survival in non-Hodgkin's lymphoma: A post hoc analysis.
Porrata LF; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Villasboas JC; Markovic SN
Leuk Res; 2019 Jun; 81():1-9. PubMed ID: 30978434
[TBL] [Abstract][Full Text] [Related]
7. Blood Graft and Outcome After Autologous Stem Cell Transplantation in Patients With Primary Central Nervous System Lymphoma.
Partanen A; Kuittinen O; Turunen A; Valtola J; Pyorala M; Kuitunen H; Vasala K; Kuittinen T; Mantymaa P; Pelkonen J; Jantunen E; Varmavuo V
J Hematol; 2021 Dec; 10(6):246-254. PubMed ID: 35059086
[TBL] [Abstract][Full Text] [Related]
8. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
Bierman PJ; Sweetenham JW; Loberiza FR; Taghipour G; Lazarus HM; Rizzo JD; Schmitz N; van Besien K; Vose JM; Horowitz M; Goldstone A;
J Clin Oncol; 2003 Oct; 21(20):3744-53. PubMed ID: 12963703
[TBL] [Abstract][Full Text] [Related]
9. Immunologic Autograft Engineering and Survival in Non-Hodgkin Lymphoma.
Porrata LF; Burgstaler EA; Winters JL; Jacob EK; Gastineau DA; Suman VJ; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Nevala W; Markovic SN
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1017-1023. PubMed ID: 26826432
[TBL] [Abstract][Full Text] [Related]
10. Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Majolino I; Pearce R; Taghipour G; Goldstone AH
J Clin Oncol; 1997 Feb; 15(2):509-17. PubMed ID: 9053472
[TBL] [Abstract][Full Text] [Related]
11. Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma.
Yoon DH; Sohn BS; Jang G; Kim EK; Kang BW; Kim C; Kim JE; Kim S; Lee DH; Lee JS; Park SJ; Park CJ; Huh J; Suh C
Transfusion; 2009 Sep; 49(9):1890-900. PubMed ID: 19453991
[TBL] [Abstract][Full Text] [Related]
12. Ten-year follow-up of pediatric patients with non-Hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation.
Giulino-Roth L; Ricafort R; Kernan NA; Small TN; Trippett TM; Steinherz PG; Prockop SE; Scaradavou A; Chiu M; O'Reilly RJ; Boulad F
Pediatr Blood Cancer; 2013 Dec; 60(12):2018-24. PubMed ID: 24038967
[TBL] [Abstract][Full Text] [Related]
13. Influence of ex vivo purging with CliniMACS CD34(+) selection on outcome after autologous stem cell transplantation in non-Hodgkin lymphoma.
Yahng SA; Yoon JH; Shin SH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Kim DW; Lee JW; Min WS; Park CW; Kim Y; Cho SG
Br J Haematol; 2014 Feb; 164(4):555-64. PubMed ID: 24266323
[TBL] [Abstract][Full Text] [Related]
14. Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma.
Porrata LF; Litzow MR; Inwards DJ; Gastineau DA; Moore SB; Pineda AA; Bundy KL; Padley DJ; Persky D; Ansell SM; Micallef IN; Markovic SN
Bone Marrow Transplant; 2004 Feb; 33(3):291-8. PubMed ID: 14676784
[TBL] [Abstract][Full Text] [Related]
15. Blood graft composition after plerixafor injection in patients with NHL.
Varmavuo V; Mäntymaa P; Nousiainen T; Valonen P; Kuittinen T; Jantunen E
Eur J Haematol; 2012 Aug; 89(2):128-35. PubMed ID: 22536949
[TBL] [Abstract][Full Text] [Related]
16. Early immune recovery after autologous transplantation in non-Hodgkin lymphoma patients: predictive factors and clinical significance.
Valtola J; Varmavuo V; Ropponen A; Selander T; Kuittinen O; Kuitunen H; Keskinen L; Vasala K; Nousiainen T; Mäntymaa P; Pelkonen J; Jantunen E
Leuk Lymphoma; 2016 Sep; 57(9):2025-32. PubMed ID: 26763346
[TBL] [Abstract][Full Text] [Related]
17. Blood graft cellular composition and posttransplant recovery in non-Hodgkin's lymphoma patients mobilized with or without plerixafor: a prospective comparison.
Valtola J; Varmavuo V; Ropponen A; Nihtinen A; Partanen A; Vasala K; Lehtonen P; Penttilä K; Pyörälä M; Kuittinen T; Silvennoinen R; Nousiainen T; Pelkonen J; Mäntymaa P; Jantunen E
Transfusion; 2015 Oct; 55(10):2358-68. PubMed ID: 26018461
[TBL] [Abstract][Full Text] [Related]
18. [Autologous stem-cell transplantations in children with non-Hodgkin lymphomas].
Wójcik B; Kowalczyk JR; Chybicka A; Wachowiak J; Drabko K; Zaucha-Prazmo A; Choma M; Gorczyńska E; Toporski J; Turkiewicz D; Kałwak K; Pieczonka A; Boruczkowski D
Przegl Lek; 2004; 61 Suppl 2():53-6. PubMed ID: 15686047
[TBL] [Abstract][Full Text] [Related]
19. Second autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma after a previous autograft: a study of the lymphoma working party of the EBMT.
Martínez C; Boumendil A; Romejko-Jarosinska J; Anagnostopoulos A; Faber E; Poiré X; Yakoub-Agha I; Akhtar S; Gurman G; Pavone V; Halaburda K; Sousa AB; Ghesquières H; Finel H; Khvedelidze I; Montoto S; Sureda A
Leuk Lymphoma; 2020 Dec; 61(12):2915-2922. PubMed ID: 32654552
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
